Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-001197)

Filing Details

Accession Number:: 0000899243-20-001197
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-14 20:26:41
Reporting Period:: 2020-01-14

Accepted Time:: 2020-01-14 20:26:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-01-14	5,000	$75.39	91,777	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	225,947	Indirect	By Reporting Person's Trust 2
Common Stock	323,526	Indirect	By Reporting Person's Trust 3
Common Stock	12,200	Indirect	By Trust 1
Common Stock	12,200	Indirect	By Trust 2
Common Stock	12,200	Indirect	By Trust 3

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $75.00 to $75.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.